Pharmaceuticals - Indian - Formulations
No data available
No data available
No data available
Particulars (in ₹ Cr.) | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
---|---|---|---|---|---|
Total Revenue | 82.79 | 61.87 | 59.54 | 30.44 | - |
Total Expenses | 68.35 | 54.88 | 53.78 | 29.65 | - |
Profit Before Tax | 14.45 | 6.98 | 5.77 | 0.79 | - |
Profit After Tax | 10.09 | 5.04 | 4.11 | 0.66 | - |
Operating Profit after Depreciation | 15.21 | 7.52 | 6.06 | 1.10 | - |
Particulars (in ₹ Cr.) | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
---|---|---|---|---|---|
Fixed Assets | 10.21 | 9.84 | 7.38 | 5.94 | - |
Total Non Current Assets | 17.66 | 12.97 | 7.96 | 6.32 | - |
Total Current Assets | 41.64 | 33.98 | 26.84 | 12.08 | - |
TOTAL ASSETS | 59.29 | 46.94 | 34.80 | 18.40 | - |
Total Shareholder's Fund | 28.64 | 15.10 | 9.99 | 5.89 | - |
Particulars (in ₹ Cr.) | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
---|---|---|---|---|---|
Net Cash from Operating Activities | 3.01 | 3.88 | 3.46 | 1.05 | - |
Net Cash used in Investing Activities | -5.03 | -3.82 | -1.89 | -1.20 | - |
Net Cash used in Financing Activities | 2.04 | - | -0.41 | 0.04 | - |
No data available
Particulars (in ₹ Cr.) | 2024-03 | 2023-12 |
---|---|---|
Total Revenue | - | - |
Total Expenses | - | - |
Profit Before Tax | - | - |
Profit After Tax | 2.34 | 1.43 |
Operating Profit after Depreciation | - | - |
Company | Price | Market Cap (in ₹ Cr) |
---|---|---|
Quest Laboratories Ltd | ₹142.15 | ₹232.94 |
Sun Pharmaceuticals Industries Ltd | ₹1,745.25 | ₹4,18,743.94 |
Divis Laboratories Ltd | ₹5,733.60 | ₹1,52,209.07 |
Cipla Ltd | ₹1,458.15 | ₹1,17,762.24 |
Torrent Pharmaceuticals Ltd | ₹3,357.15 | ₹1,13,616.11 |
Mankind Pharma Ltd | ₹2,488.40 | ₹1,02,663.15 |
24 Jan 2025, 12:58 pm
07 Nov 2024, 04:16 pm
10 Aug 2024, 05:23 pm
23 May 2024, 11:19 am